'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat
--------------------------------------------------------------------
Source: CNBC
Published: 2026-09-08 23:30 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Economy & Finance, Financial Markets, Labour & Workers, Drugs, US Politics, Business & Economy
--------------------------------------------------------------------
Snippet:
American patients would ultimately bear the cost of President Donald Trump's threatened tariffs on generic drugs, the CEO of Swiss pharmaceutical company Sandoz told CNBC, warning that manufacturers could be forced to raise prices or stop supplying some medicines.
--------------------------------------------------------------------